Thanks to a greater understanding of human leukocyte antigen (HLA) function, researchers can now work toward developing new cancer immunotherapies.

The HLA (human leukocyte antigen) system of cell surface proteins contributes to the regulation of the immune system. Yet certain antigens can make a significant difference. Patients with some types of HLA are at higher risk for autoimmune diseases, infectious diseases, or cancer. Thanks to an improved understanding of HLA function, researchers can now develop new cancer immunotherapies.

Our Product Manager for cells and media and HLA expert Lisa Hamelmann will talk you through the following topics:

  • HLA restriction: finding and binding
  • HLA and diseases: activating autoimmune responses
  • HLA and cancer: how cancer cells escape recognition
  • New therapeutic options: harnessing HLA for cancer immunotherapy
  • HLA-typed cells: an important control system to test new immunotherapies

Dr. Lisa Hamelmann, Product Manager Cells & Media Dr. Lisa Hamelmann

Download the white paper

Learn more about the significance HLA has for developing cell therapies.

Download here

Related product

Related resources

HLA-Typed Human Primary Cells
We offer a unique range of human HLA-typed cell donors. Send your request for HLA-typed cells and start your experiments immediately without time-consuming donor screenings.

Application: Immuno-Oncology
Our immuno-oncology portfolio contains characterised human primary cells, including vascular and microvascular endothelial cells, mononuclear cells, macrophages, monocytes and blood progenitor cells – plus optimized cell culture growth medium for each cell type.

Applications: Cancer Media Toolbox
We have developed a toolbox of cancer cell media to establish primary cancer cell lines from biopsies, develop 3D tumor models or build screening assays. Discover our solutions for your workflow.